Analyst Price Targets — ORGO
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| November 20, 2025 12:10 pm | — | BTIG | $9.00 | $5.14 | TheFly | Organogenesis price target raised to $9 from $7 at BTIG |
| March 5, 2025 12:21 pm | — | Morgan Stanley | $6.00 | $6.01 | TheFly | Organogenesis price target raised to $6 from $4 at Morgan Stanley |
| June 28, 2024 8:01 am | Brooks O'Neil | Lake Street | $5.00 | $2.64 | TheFly | Organogenesis initiated with a Buy at Lake Street |
Latest News for ORGO
Organogenesis Holdings Inc. (ORGO) Q4 2025 Earnings Call Transcript
CANTON, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine and tissue innovations company focused on empowering healing through the development, manufacturing, and sale of products for the advanced wound care, and surgical and sports medicine markets, today reported financial results for the fourth quarter and the year ended December 31, 2025.
CANTON, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced that fourth quarter and fiscal year 2025 financial results will be reported after the market closes on Thursday,…
NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Organogenesis Holdings Inc. (“Organogenesis” or the “Company”) (NASDAQ: ORGO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
NEW YORK, Jan. 29, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Organogenesis Holdings Inc. ("Organogenesis" or the "Company") (NASDAQ: ORGO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ORGO.
U.S. House Trading
No House trades found for ORGO.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.